These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 23373580)

  • 1. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the revised Addenbrooke's Cognitive Examination (ACE-R) for detecting mild cognitive impairment and dementia in a Japanese population.
    Yoshida H; Terada S; Honda H; Kishimoto Y; Takeda N; Oshima E; Hirayama K; Yokota O; Uchitomi Y
    Int Psychogeriatr; 2012 Jan; 24(1):28-37. PubMed ID: 21843399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
    Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
    Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Addenbrooke's cognitive examination for detecting early dementia in a Japanese population.
    Yoshida H; Terada S; Honda H; Ata T; Takeda N; Kishimoto Y; Oshima E; Ishihara T; Kuroda S
    Psychiatry Res; 2011 Jan; 185(1-2):211-4. PubMed ID: 20537725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Cuban Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Cognitive Impairment.
    Broche-Pérez Y; López-Pujol HA
    Dement Geriatr Cogn Disord; 2017; 44(5-6):320-327. PubMed ID: 29393151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
    Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
    Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia.
    Peixoto B; Machado M; Rocha P; Macedo C; Machado A; Baeta É; Gonçalves G; Pimentel P; Lopes E; Monteiro L
    Adv Clin Exp Med; 2018 Jun; 27(6):781-786. PubMed ID: 29790690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation study of the Italian Addenbrooke's Cognitive Examination Revised in a young-old and old-old population.
    Pigliautile M; Ricci M; Mioshi E; Ercolani S; Mangialasche F; Monastero R; Croce MF; Federici S; Mecocci P
    Dement Geriatr Cogn Disord; 2011; 32(5):301-7. PubMed ID: 22262124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia.
    Yang L; Li X; Yin J; Yu N; Liu J; Ye F
    J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):205-210. PubMed ID: 30987514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychometric properties and diagnostic usefulness of the Addenbrooke's Cognitive Examination-Revised in a Chilean elderly sample].
    Muñoz-Neira C; Henríquez Ch F; Ihnen J J; Sánchez C M; Flores M P; Slachevsky Ch A
    Rev Med Chil; 2012 Aug; 140(8):1006-13. PubMed ID: 23282773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals.
    North C; Heatley MH; Utoomprurkporn N; Bamiou DE; Costafreda SG; Stott J
    Eur J Neurol; 2021 Jun; 28(6):1820-1828. PubMed ID: 33486875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Portuguese version of Addenbrooke's Cognitive Examination-Revised (ACE-R) in the diagnosis of subcortical vascular dementia and Alzheimer's disease.
    Gonçalves C; Pinho MS; Cruz V; Pais J; Gens H; Oliveira F; Santana I; Rente J; Santos JM
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2015; 22(4):473-85. PubMed ID: 25430606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Spanish version of the Addenbrooke's Cognitive Examination in a rural community in Spain.
    García-Caballero A; García-Lado I; González-Hermida J; Recimil M; Area R; Manes F; Lamas S; Berrios G
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):239-45. PubMed ID: 16477583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Egyptian-Arabic Version of the Addenbrooke's Cognitive Examination III (ACE-III) in Diagnosing Dementia.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Abdel Aziz K
    Dement Geriatr Cogn Disord; 2020; 49(2):179-184. PubMed ID: 32417842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Addenbrooke's cognitive examination (ACE) in a Persian-speaking population.
    Pouretemad HR; Khatibi A; Ganjavi A; Shams J; Zarei M
    Dement Geriatr Cogn Disord; 2009; 28(4):343-7. PubMed ID: 19864908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addenbrooke's Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia.
    Larner AJ
    Clin Neurol Neurosurg; 2007 Jul; 109(6):491-4. PubMed ID: 17509752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.